Regeneron Pharmaceuticals Regn Q3 2018 Results Earnings Call Transcript | Latest News RSS feed

Regeneron Pharmaceuticals Regn Q3 2018 Results Earnings Call Transcript - Latest News


Regeneron Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript

Regeneron Pharmaceuticals (NASDAQ:REGN) Q3 2013 Earnings Call ... on today's call. Information regarding our use of non-GAAP financial measures and a reconciliation of these measures to GAAP are ... read more

Regeneron (REGN) to Report Q3 Earnings: Is a Beat in Store?

Regeneron Pharmaceuticals, Inc. REGN is scheduled to release third-quarter 2018 results on Nov 6 ... particularly on Eylea and Dupixient’s uptake during the earnings call. Investors are also expected ... read more

Biotech Stock Roundup: Regeneron Delivers Strong Q3 Results, Cellectis Clinical Hold Lifted

Key highlights in the biotech sector over the past week include earnings results from companies like Regeneron Pharmaceuticals, Inc. REGN and the lifting ... for the first quarter of 2018 (Read more: ... read more

Looking for another news?


Is Regeneron Pharmaceuticals the Best Biotech Stock to Buy?

It may not get the attention as often as larger-cap biotech stocks like Celgene Corp. (NASDAQ:CELG) and Gilead Sciences (NASDAQ:GILD), but a bunch of recent drug approvals could soon change that for ... read more


Is Regeneron Pharmaceuticals the Best Biotech Stock to Buy?

A full transcript follows the video. 10 stocks we like better than Regeneron Pharmaceuticals ... hitting the market in, we'll call it 18 months. Harjes: Yeah, when you look at Regeneron's most recent ... read more

Aerpio Pharmaceuticals' (ARPO) CEO Steve Hoffman on Q3 2018 Results - Earnings Call Transcript

Aerpio Pharmaceuticals Inc. (NASDAQ:ARPO) Q3 2018 Earnings Conference Call November 7 ... Thanks Steve and thanks Adnan for the question. Yes, so those results came out in the Regeneron press release, ... read more

Eli Lilly (LLY) to Report Q3 Earnings: What's in the Cards?

Eli Lilly and Company LLY will report third-quarter 2018 ... an earnings beat in their upcoming releases. Regeneron Pharmaceuticals, Inc. REGN has an Earnings ESP of +4.65% and a Zacks Rank #3. The ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us